Aortik Kapak Hastalıklarında Sezaryen Anestezisi
Synopsis
Cardiovascular diseases during pregnancy are among the leading causes of maternal morbidity and mortality, with rheumatic heart diseases frequently observed. Among aortic valve diseases, aortic stenosis (AS) and aortic regurgitation (AR) require a multidisciplinary, personalized, and hemodynamically meticulous approach during cesarean anesthesia. In pregnant women with severe AS, primary hemodynamic goals include maintaining sinus rhythm and a normal heart rate, ensuring adequate hydration, and preserving systemic vascular resistance to avoid hypotension and prevent myocardial ischemia. Should hypotension occur, the pure alpha-agonist phenylephrine is the first choice, whereas tachycardia-inducing drugs and standalone spinal anesthesia—which carries a risk of rapid sympathectomy—must be strictly avoided. General anesthesia is considered the gold standard for AS patients with heart failure and instability, whereas slowly titrated epidural anesthesia may be preferred in stable cases. Conversely, in aortic regurgitation, bradycardia—which prolongs diastole and increases regurgitation—must be avoided, keeping the heart rate within 80-100 bpm while maintaining low afterload and preload. Neuraxial anesthesia techniques are generally well tolerated in AR patients as they reduce afterload. Postpartum, slow infusion of oxytocin is safely used as a uterotonic, while ergometrine, which can trigger coronary vasospasm, must be avoided. Throughout this process, invasive arterial and central venous catheterization alongside close monitoring in the intensive care unit play a critical role in preserving hemodynamic stability.
References
Berg CJ, Callaghan WM, Syverson C, et al. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116:1302-1309.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-3241.
Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066-1074.
Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–521.
Swan L. Congenital heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014;28(4):495-506.
Rutherford JD. Heart failure in pregnancy. Curr Heart Fail Rep. 2012;9:277-281.
Canobbio MM, Warnes CA, Aboulhosn J, et al; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Management of Pregnancy in Patients with Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals from the American Heart Association. Circulation. 2017;135:e50-e87.
Lindley KJ, Conner SN, Cahill AG, et al. Contraception and Pregnancy Planning in Women with Congenital Heart Disease. Curr Treat Options Cardiovasc Med. 2015;17(11):50.
Arendt KW, Lindley KJ. Obstetric anesthesia management of the patient with cardiac disease. Int J Obstet Anesth. 2019;37:73-85.
Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520-1525.
Ford AA, Wylie BJ, Waksmonski CA, et al. Maternal congenital cardiac disease: outcomes of pregnancy in a single tertiary care center. Obstet Gynecol. 2008;112:828-833.
Maxwell BG, El-Sayed YY, Riley ET, et al. Peripartum outcomes and anaesthetic management of parturients with moderate to complex congenital heart disease or pulmonary hypertension. Anaesthesia. 2013;68:52-59.
Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women with Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018;71:2419-2430.
Goldszmidt E, Macarthur A, Silversides C, et al. Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. Int J Obstet Anesth. 2010;19:266-272.
David H. Chestnut. Cardiovascular disease. David H Chestnut, eds. Obstetric Anaesthesia - Principles and Practice. 5th ed. Philadelphia: Elsevier-Saunders; 2014: 960-1002.
Silversides CK, Colman JM, Sermer M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91:1386-1389.
Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893-899.
Datt V, Tempe DK, Virmani S, et al. Anesthetic management for emergency cesarean section and aortic valve replacement in a parturient with severe bicuspid aortic valve stenosis and congestive heart failure. Ann Card Anaesth. 2010;13:64-68.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35-e71.
Ioscovich AM, Goldszmidt E, Fadeev AV, et al. Peripartum anesthetic management of patients with aortic valve stenosis: a retrospective study and literature review. Int J Obstet Anesth. 2009;18:379-386.
Tzemos N, Silversides CK, Colman JM, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J. 2009;157:474-480.
Kampman MA, Valente MA, van Melle JP, et al; ZAHARA II investigators. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart. 2016;102:1302-1308.
Akpinar O. Gebelik ve kapak hastaliklari [Pregnancy and heart valve disease]. Anadolu Kardiyol Derg. 2009;9 Suppl 1:25-34.
Brown J, Morgan‑Hughes NJ. Aortic stenosis and non‑cardiac surgery. Contin Educ Anaesth Crit Care Pain 2005;5(1):1‑4.
Ramanathan S, Grant GJ. Vasopressor therapy for hypotension due to epidural anesthesia for cesarean section. Acta Anaesthesiol Scand. 1988;32(7):559-65.
UpToDate (2021). Anesthesia for labor and delivery in high-risk heart disease: Specific lesions. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions#H855740842 adresinden ulaşılmıştır.
UpToDate (2021). Anesthesia for labor and delivery in high-risk heart disease: General considerations. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations?sectionName=Neuraxial%20analgesia%20for%20labor&topicRef=93919&anchor=H77919293&source=see_link#H77919293 adresinden ulaşılmıştır.
UpToDate (2021). Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease/print adresinden ulaşılmıştır.
Brian JE Jr, Seifen AB, Clark RB, et al. Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth. 1993;5:154-157.
Easterling TR, Chadwick HS, Otto CM, Benedetti TJ. Aortic stenosis in pregnancy. Obstet Gynecol. 1988;72:113-118.
Fanning N, Balki M, Sermer M, et al. Noninvasive cardiac output monitoring during general anesthesia for Cesarean delivery in a patient with severe aortic stenosis. Can J Anaesth. 2011;58:837-841.
Leatherbarrow AC. Management of emergency caesarean section in a patient with decompensated critical aortic stenosis. Journal of Obstetric Anaesthesia and Critical Care. 2018 8(1):50.
Ghosh S, Marton S. Anesthetic management for cesarean delivery in a patient with severe aortic stenosis and severe obesity. Obes Surg. 2011;21:264-266.
Picker O, Schwarte LA, Schindler AW, et al. Desflurane increases heart rate independent of sympathetic activity in dogs. Eur J Anesthesiol. 2003;20(12):945–951.
Hemmerling T, Olivier JF, Le N, et al. Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting. Eur J Anaesthesiol. 2008;25(3):230-236.
Tamhane P, O'Sullivan G, Reynolds F. Oxytocin in parturients with cardiac disease. Int J Obstet Anesth. 2006 Oct;15(4):332-333.
Burt CC, Durbridge J. Management of cardiac disease in pregnancy. Continuing Education in Anaesthesia, Critical Care & Pain. 2009;9:44 47.
Leśniak-Sobelga A, Tracz W, KostKiewicz M, et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome. Int J Cardiol. 2004;94:15-23.